Rosmerta Digital Services was not approaching the SME market with a token-sized issue. The company was preparing to raise ₹206.33 crore through its initial public offering, with a fresh issue of shares and a price band of ₹140 to ₹147.

The IPO was scheduled to open for subscription on November 18, 2024, after the anchor book was to open on November 14. The proposed issue came at a time when Rosmerta Digital was reporting rapid growth.

Incorporated in 2021, the company had built a business around digital and technology-enabled services for the automotive ecosystem, including vehicle registration, documentation and related services. Its revenue from operations rose sharply from around ₹297.9 crore in FY23 to approximately ₹841.9 crore in FY24.

That growth was a major part of the investment proposition. The IPO was effectively asking public-market investors to buy into a relatively young company that had scaled quickly and was now looking to use the public markets to fund the next phase of its expansion.

On paper, therefore, Rosmerta’s IPO was a significant SME-market event. The size of the issue, the pace of the company’s growth and the valuation being sought meant that there was plenty for investors to examine in the company’s DRHP.

And then, just as the issue was about to enter the market, the timetable changed.

Then The IPO Suddenly Stopped

On November 13, 2024, Rosmerta Digital Services announced that it was postponing its IPO. The company’s stated explanation was straightforward: adverse market conditions.

There was, however, another development unfolding around the same time.

—Reports emerged that complaints had reached the Securities and Exchange Board of India concerning disclosures in Rosmerta Digital’s draft offer documents and alleged violations involving persons associated with the promoters.

—The allegations included claims of concealment of material information and questions surrounding the alleged involvement of Vivek Nagpal, the father of the company’s promoter-directors.

Those were allegations, not findings of wrongdoing. Rosmerta’s management disputed the claims, including the suggestion that Vivek Nagpal had any direct or indirect involvement in the company’s operations.

But the timing was difficult to ignore. The IPO had been preparing to open its anchor book. Complaints had reportedly reached the regulator. The issue was then postponed. And while the company publicly pointed to market conditions, subsequent reporting suggested that regulatory concerns surrounding the offer were also part of the picture.

It would be inaccurate to say that SEBI publicly declared Rosmerta’s disclosures false or that the regulator formally found the company guilty of wrongdoing. No such public finding is being asserted here.

But it would be equally incomplete to describe the episode simply as an SME IPO caught in an unfavourable market. Because shortly afterwards, CARE Ratings itself took notice of the controversy.

On November 18, 2024, CARE placed ₹65 crore of Rosmerta Technologies’ long-term bank facilities and ₹72.58 crore of short-term facilities – ₹137.58 crore in total – on Rating Watch with Negative Implications. The rating agency specifically referred to allegations concerning concealment of material facts in Rosmerta Digital Services’ DRHP and the alleged involvement of Vivek Nagpal. Management’s denial was also recorded.

That is where the Rosmerta story stops being simply about an IPO that missed its window. It becomes a question of what happened to the concerns that emerged just before the window closed – what happened to the complaints after the IPO disappeared from the market?

So What Happened To The Complaints?

This is where the public record becomes considerably less clear.

The complaints that surfaced around the IPO raised questions about the disclosures made in Rosmerta Digital Services’ DRHP and alleged conduct involving people associated with the promoter group. Contemporary reports said the complaints had reached SEBI and that the regulator had communicated with the company and its merchant bankers around the IPO.

What is missing from the publicly visible record is therefore almost as important as what is present.

There is no public SEBI order that we have identified establishing that Rosmerta committed the alleged disclosure violations. There is also no clear public regulatory document that says the complaints were rejected, the company was formally cleared, or that the concerns had been conclusively resolved.

That leaves an uncomfortable gap in the chronology.

The IPO was postponed in November 2024. The company attributed the decision to adverse market conditions. Around the same time, complaints concerning its disclosures were reported to have reached the regulator. CARE subsequently placed the promoter company’s bank facilities on rating watch, specifically referring to those allegations.

And then the IPO simply did not return.

• If the complaints were investigated and resolved, what was the outcome?
• If the concerns resulted in changes to the disclosures, what changed?
• If the matter was closed without regulatory action, was there any public communication to that effect?
• And if the complaints remained under consideration, what happened to the IPO process while they did?

These are not questions about whether Rosmerta is guilty or innocent of allegations that have not been established. They are questions about the information available to investors.

For a company seeking to return to the public markets, that distinction matters. An investor does not merely need to know that an earlier IPO was postponed. They need to understand why it was postponed, whether the concerns that surrounded it were resolved, and whether anything in the company’s disclosures or corporate structure changed as a result.

Nearly two years later, that is precisely where the Rosmerta story remains incomplete.

Nearly Two Years Later, Where Is The IPO?

The simplest way to test Rosmerta’s explanation for the 2024 postponement is to look at what happened afterwards.

If adverse market conditions were the principal reason for delaying the issue, the logical expectation would have been that the company would eventually return when conditions improved. The Indian equity market did not remain frozen for two years. SME IPO activity continued, and companies continued to raise capital.

Rosmerta Digital Services, however, did not announce a fresh IPO timetable.

The original issue – a ₹206.33 crore offering with a price band of ₹140 to ₹147 – remains part of the company’s public IPO documentation, but there has been no publicly announced replacement date for the issue. In other words, the IPO has not exactly been cancelled in a dramatic announcement. It has simply remained in suspension.

That creates an obvious question.

What changed between November 2024 and October 2026?

If the problem was market timing, two years should have provided multiple opportunities to revisit the issue. If the problem was the complaints, then the status of those complaints becomes even more relevant. And if the company itself decided that the IPO was no longer the appropriate route to raise capital, investors deserve to know that too.

There is another complication.

An IPO does not exist in isolation from the company that filed the original DRHP. Businesses change. Revenues change. debt changes. Related-party relationships can change. Group structures can change. Litigation can arise and disappear. New risks can emerge.

The Rosmerta of 2026 is therefore not necessarily the same corporate proposition that investors were being asked to evaluate in 2024.

Yet there has been no new public issue timetable through which investors can assess those changes. That makes the question of what happened to the IPO more than a question of scheduling.

It is a question of whether the original public-market proposition is still the same one.

What Changed Inside Rosmerta While The IPO Stayed Away?

The two-year gap was not a period in which nothing happened at Rosmerta.

In March 2025, Rosmerta Digital Services and another group company became involved in insolvency proceedings against Ola Electric over alleged unpaid dues. Rosmerta Digital’s claim was reported to be more than ₹22 crore. Ola disputed the claims, and the matter was subsequently settled, following which the insolvency proceedings were withdrawn.

That episode does not establish anything about the 2024 IPO controversy. But it does show that Rosmerta’s operating business continued to evolve after the proposed listing disappeared.

There was also a separate corporate-compliance issue involving Rosmerta Technologies. In October 2025, the Registrar of Companies, Delhi passed an order concerning failures in maintaining consecutive numbering of minutes of certain board and general meetings during earlier financial years. The company acknowledged the lapse and said the issue had been rectified.

Again, this is not evidence that the IPO complaints were valid. Nor should a historical minutes-compliance issue be presented as equivalent to the allegations surrounding the DRHP.

The more consequential change came in 2026.

Rosmerta Safety Systems was amalgamated into Rosmerta Technologies with effect from April 11, 2026. Under the scheme, the assets, liabilities, rights, obligations, employees and business operations of Rosmerta Safety Systems were transferred to Rosmerta Technologies as a going concern.

That matters because Rosmerta Safety Systems was not an irrelevant entity sitting outside the group’s business history. It had previously carried substantial investments in group companies and had been part of the wider corporate structure examined by CARE when the 2024 IPO controversy was unfolding.

The post-2026 Rosmerta group therefore deserves to be looked at on its own terms.

• What liabilities moved across in the amalgamation?
• What claims or obligations remain outstanding?
• What does the consolidated group now look like compared with the structure described in the 2024 IPO documents?
• And if Rosmerta Digital eventually returns to the public markets, will investors be looking at essentially the same group economics that existed when the original DRHP was filed?

Those questions do not prove that anything improper occurred. But they underline why simply carrying a two-year-old IPO document forward is not enough.

The company has changed while the IPO has remained frozen. And until Rosmerta returns with a fresh timetable and updated disclosures, investors are left with an unusually long gap between the company they were originally asked to evaluate and the company that may eventually seek their money.

The Bigger Question Is Not Whether Rosmerta Can Eventually IPO

Rosmerta can still return to the public markets. There is nothing inherently unusual about an IPO being postponed, a company waiting for better conditions and an issue being brought back at a later date.

The difficulty here is the length of the gap and what happened at the beginning of it.

The 2024 IPO did not disappear into a vacuum. It was postponed at a point when complaints concerning the company’s DRHP had reportedly reached SEBI. CARE Ratings subsequently placed ₹137.58 crore of Rosmerta Technologies’ bank facilities on Rating Watch with Negative Implications and specifically referred to allegations concerning the disclosure of material facts and the alleged involvement of Vivek Nagpal.

Rosmerta disputed those allegations.

There is also no public SEBI finding establishing that the allegations were proved. That matters and should not be glossed over. But neither does the public record we have found provide a clear, final regulatory account of what happened to those complaints.

And that is ultimately the issue for prospective investors.

• If the complaints were investigated and closed, investors should be able to understand the outcome.
• If the company made changes to its disclosures, those changes should be identifiable.
• If the regulator found no actionable violation, that too would be relevant information.
• And if the matters remained unresolved, that would obviously be material to any future attempt to raise money from the public.
• The question is therefore not whether Rosmerta should be allowed to IPO.

It is whether, before it does, investors will be given a sufficiently updated account of what happened between the original DRHP and whatever prospectus eventually comes before them.

That becomes even more important because the corporate group has not stood still. There have been disputes, regulatory and compliance developments, changes in group-company relationships and, in 2026, the amalgamation of Rosmerta Safety Systems into Rosmerta Technologies.

A future IPO would therefore have to be assessed against a corporate structure that has evolved materially since 2024.

If Rosmerta eventually returns to the public markets, investors will not just be buying the business described in a 2024 DRHP. They will be buying into a company and group that have changed over the intervening two years.

The market therefore deserves more than a new IPO date. It deserves an updated explanation of what happened to the complaints, what was examined, what was resolved and what, if anything, changed.

Because an IPO can be postponed for two years. The questions that caused investors to pause should not have to wait that long for an answer.